95557-5
Detection basis of Tumor
Active
Term Description
Whether a tumor is discovered & diagnosed incidentally or because of clinical and/or biochemical presentation with adrenal hormonal excess, as part of cancer staging/surveillance imaging, or other mechanisms such as mass effect and B symptoms.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Detection basis
- Property
- Type
- Time
- Pt
- System
- Tumor
- Scale
- Nom
- Method
Additional Names
- Short Name
- Detection basis Tumor
Example Answer List: LL5565-8
Source: Mayo Medical LaboratoriesAnswer | Code | Score | Answer ID |
---|---|---|---|
Incidental | LA21593-1 | ||
Cancer staging | LA30894-2 | ||
As part of clinical testing | LA30895-9 | ||
Other | LA46-8 |
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
95556-7 | Adrenal cancer risk assessment and urine steroid fractions panel |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Base de detección: |
it-IT | Italian (Italy) | Base di rilevamento: Synonyms: Anamnesi Neoplasia Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 检测依据: Synonyms: 分类型应答; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=95557-5
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright